NEW YORK (GenomeWeb News) — As expected, a group of Tripos senior executives will buy the company’s Discovery Research subsidiary for £548,000 ($1.1 million), according to a binding letter of intent the company filed with the US Securities and Exchange commission on April 12.
 
The company said in March that if a planned sale of the business to Provid Pharmaceuticals were to fall through then some of its management might buy the group themselves.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.